Journal of Clinical Medicine (May 2023)

Myocardial Infarction with Non-Obstructive Coronary Arteries (MINOCA): Focus on Coronary Microvascular Dysfunction and Genetic Susceptibility

  • Paolo Severino,
  • Andrea D’Amato,
  • Silvia Prosperi,
  • Vincenzo Myftari,
  • Lorenzo Colombo,
  • Elisa Tomarelli,
  • Alice Piccialuti,
  • Gianluca Di Pietro,
  • Lucia Ilaria Birtolo,
  • Viviana Maestrini,
  • Roberto Badagliacca,
  • Gennaro Sardella,
  • Francesco Fedele,
  • Carmine Dario Vizza,
  • Massimo Mancone

DOI
https://doi.org/10.3390/jcm12103586
Journal volume & issue
Vol. 12, no. 10
p. 3586

Abstract

Read online

Among the most common causes of death worldwide, ischemic heart disease (IHD) is recognized to rank first. Even if atherosclerotic disease of the epicardial arteries is known as the leading cause of IHD, the presence of myocardial infarction with non-obstructive coronary artery disease (MINOCA) is increasingly recognized. Notwithstanding the increasing interest, MINOCA remains a puzzling clinical entity that can be classified by distinguishing different underlying mechanisms, which can be divided into atherosclerotic and non-atherosclerotic. In particular, coronary microvascular dysfunction (CMD), classifiable in non-atherosclerotic mechanisms, is a leading factor for the pathophysiology and prognosis of patients with MINOCA. Genetic susceptibility may have a role in primum movens in CMD. However, few results have been obtained for understanding the genetic mechanisms underlying CMD. Future studies are essential in order to find a deeper understanding of the role of multiple genetic variants in the genesis of microcirculation dysfunction. Progress in research would allow early identification of high-risk patients and the development of pharmacological, patient-tailored strategies. The aim of this review is to revise the pathophysiology and underlying mechanisms of MINOCA, focusing on CMD and actual knowledge about genetic predisposition to it.

Keywords